Shares ofAnika Therapeutics Inc(NASDAQ:ANIK), a small-cap biotech focused on regenerativemedicine, were down 36% as of 11:10 a.m. EDT on Tuesday. The stock plummetedafter the company reported data from an important phase 3 study.
Headlines about Spherix (NASDAQ:SPEX) have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale
MGM Resorts International (MGM) always had two things going for it: It’s large Las Vegas footprint to counter the weakness in Macau, and it’s real-estate, which it spun off into MGM Growth Properties (MGP). But when MGM reported weaker than expected earnings this morning, it wasn’t a good sign that Las Vegas was disappointing. Wells Fargo’sCameron McKnight explains:
On Friday, our Elite Opportunity Pronewsletter suggestedsmall cap fiber optic network stock Clearfield Inc (NASDAQ: CLFD) as a long/bullish trade:
When we think about infrastructure buildout, it’s actually companies like Clearfield that will stand to benefit on the tech front. It’s often too cost prohibitive in many parts of the country to lay fiber below ground for various natural....More>>>
Springtime — or the second calendar quarter of the year — generally isn’t a great one for the broad market. While the S&P 500 tends to do well during the first three months of the year, it hits a headwind in the second three. Not so for small-cap stocks.
The S&P 600 Small Cap Index, which measures the performance of companies with market capitalizations between....More>>>
Howard Schultz’s departure as CEO does not affect Starbucks’s (NASDAQ:SBUX) outlook because he has put in place the right strategy for the long term. While sixteen years ago his standing down as CEO led to a disappointing period for the company, this time it is different. The company is focused on emerging market expansion, the delivery of premium products to create a new niche and in....More>>>
The US Treasury market’s implied inflation forecast has surged in recent days, albeit after reaching unusually low levels last month. Nonetheless, the rollercoaster of revising expectations rolls on, and this time there’s an upside bias bubbling. The spread between the nominal 10-year yield and its inflation-indexed counterpart reached 1.48% yesterday (Mar. 1), based on daily data from....More>>>
We listened to Cempra (NASDAQ: CEMP) management’s investor conference call after receiving the Complete Response Letter (CRL) from the FDA regarding regulatory application for Solithromycin’s approval for the treatment of adult community-acquired bacterial pneumonia (CABP). The management plans to meet with the FDA to discuss FDA’s request for a comparative safety trial to study....More>>>
Chambers CEO: Already Working With Trump to Kill DOL Fiduciary Rule
Why Jack Bogle Prefers Index Funds to Index ETFs
The Department of Labor’s Conflict of Interest Rule, if implemented in its current form, will force advisors to choose between employer-sponsored retirement plan business and traditional wealth management, according to....More>>>
Do we need to remind you how hard biotech stocks have been hit this year? If you read this blog, probably not, but we’ll do it anyway. The iShares Nasdaq Biotechnology ETF (IBB) has fallen 24%, while Gilead Sciences (GILD) has declined 8.7%, Biogen (BIIB) has fallen 17%, Celgene (CELG) has dropped 16%, and Regeneron Pharmaceuticals (REGN) has plunged 32%. Yet despite these drops–and....More>>>
That would certainly seem to be the case, given its stock market performance over the last couple of years.
After reporting almost flat user growth for the last couple of quarters, the San Francisco-based company reported mixed earnings yesterday. It beat analyst expectations for revenue but fell short in user numbers and future guidance. (See also:....More>>>
Stocks opened lower on Monday on concerns about the trade spat with China, but recovered somewhat during the session. TheDow Jones Industrial Average (DJINDICES:^DJI)and theS&P 500 (SNPINDEX:^GSPC)both closed in negative territory, but near highs for the day.
Aramark (NYSE: ARMK) and Main Street Capital (NYSE:MAIN) are both mid-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst re